Maxing out with chemoimmunotherapy in extensive-stage small cell lung cancer.

CANASLAN K., Xiao L., Leal T.

Chinese clinical oncology, vol.14, no.2, pp.24, 2025 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 2
  • Publication Date: 2025
  • Doi Number: 10.21037/cco-25-5
  • Journal Name: Chinese clinical oncology
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.24
  • Keywords: Small cell lung cancer (SCLC), anti-programmed cell death-1 (anti-PD-1), chemoimmunotherapy, anti-programmed death-ligand 1 (anti-PD-L1)
  • Dokuz Eylül University Affiliated: Yes